当前位置: X-MOL 学术Bioorg. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identification of an ethyl 5,6-dihydropyrazolo[1,5-c]quinazoline-1-carboxylate as a catalytic inhibitor of DNA gyrase.
Bioorganic & Medicinal Chemistry ( IF 3.5 ) Pub Date : 2020-03-13 , DOI: 10.1016/j.bmc.2020.115439
Arturo L Aguirre 1 , Pratik R Chheda 1 , Sarah R C Lentz 2 , Hailey A Held 2 , Natalie P Groves 2 , Hiroshi Hiasa 2 , Robert J Kerns 1
Affiliation  

Fluoroquinolones are a class of antibacterial agents used clinically to treat a wide array of bacterial infections and target bacterial type-II topoisomerases (DNA gyrase and topoisomerase IV). Fluoroquinolones, however potent, are susceptible to bacterial resistance with prolonged use, which limits their use in the clinic. Quinazoline-2,4-diones also target bacterial type-II topoisomerases and are not susceptible to bacterial resistance similar to fluoroquinolones, however, their potency pales in comparison to fluoroquinolones. To meet the increasing demand for antibacterial development, nine modified quinazoline-2,4-diones were developed to probe quinazoline-2,4-dione structure modification for possible new binding contacts with the bacterial type-II topoisomerase, DNA gyrase. Evaluation of compounds for inhibition of the supercoiling activity of DNA gyrase revealed a novel ethyl 5,6-dihydropyrazolo[1,5-c]quinazoline-1-carboxylate derivative as a modest inhibitor of DNA gyrase, having an IC50 of 3.5 μM. However, this ethyl 5,6-dihydropyrazolo[1,5-c]quinazoline-1-carboxylate does not trap the catalytic intermediate like fluoroquinolones or typical quinazoline-2,4-diones do. Thus, the ethyl 5,6-dihydropyrazolo[1,5-c]quinazoline-1-carboxylate derivative discovered in this work acts as a catalytic inhibitor of DNA gyrase and therefore represents a new structural type of catalytic inhibitor of DNA gyrase.

中文翻译:

5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯作为DNA促旋酶的催化抑制剂的鉴定。

氟喹诺酮类是临床上用于治疗多种细菌感染和靶向细菌II型拓扑异构酶(DNA促旋酶和拓扑异构酶IV)的一类抗菌剂。然而,氟喹诺酮类药物很强效,长时间使用对细菌具有抵抗力,这限制了它们在临床上的使用。喹唑啉-2,4-二酮也靶向细菌II型拓扑异构酶,与氟喹诺酮类相似,对细菌的耐药性不敏感,但是,与氟喹诺酮类相比,它们的药效低下。为了满足对抗菌素开发的不断增长的需求,开发了九种修饰的喹唑啉-2,4-二酮,以探测喹唑啉-2,4-二酮的结构修饰,以寻找与细菌II型拓扑异构酶,DNA促旋酶的新结合接触。化合物对DNA促旋酶超螺旋活性的抑制作用评估显示,新型的5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯衍生物是DNA促旋酶的适度抑制剂,IC50为3.5μM。但是,这种5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯不能像氟喹诺酮或典型的喹唑啉-2,4-二酮那样捕获催化中间体。因此,在这项工作中发现的5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯衍生物可作为DNA促旋酶的催化抑制剂,因此代表了一种新型的DNA促旋酶催化抑制剂。5-c]喹唑啉-1-羧酸酯不像氟喹诺酮类或典型的喹唑啉-2,4-二酮类那样捕获催化中间体。因此,在这项工作中发现的5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯衍生物可作为DNA促旋酶的催化抑制剂,因此代表了一种新型的DNA促旋酶催化抑制剂。5-c]喹唑啉-1-羧酸酯不像氟喹诺酮类或典型的喹唑啉-2,4-二酮类那样捕获催化中间体。因此,在这项工作中发现的5,6-二氢吡唑并[1,5-c]喹唑啉-1-羧酸乙酯衍生物可作为DNA促旋酶的催化抑制剂,因此代表了一种新型的DNA促旋酶催化抑制剂。
更新日期:2020-04-20
down
wechat
bug